Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical pharmacology of arabinofuranosyladenine in combination with deoxycoformycin.

× No keyword cloud information.

14 in total

1. Mode of action of 9-beta-D-arabinofuranosyladenine on the synthesis of DNA, RNA, and protein in vivo and in vitro.

Authors: W E Müller; H J Rohde; R Beyer; A Maidhof; M Lachmann; H Taschner; R K Kahn
Journal: Cancer Res Date: 1975-08 Impact factor: 12.701

2. 9-beta-D-Arabinofuranosyladenine as a tool to study herpes simplex virus DNA replication in vitro.

Authors: W E Müller; R K Zahn; R Beyer; D Falke
Journal: Virology Date: 1977-02 Impact factor: 3.616

3. Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin.

Authors: G A LePage; L S Worth; A P Kimball
Journal: Cancer Res Date: 1976-04 Impact factor: 12.701

4. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.

Authors: C E Cass; T H Au-Yeung
Journal: Cancer Res Date: 1976-04 Impact factor: 12.701

5. Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines.

Authors: H J Schaeffer; C F Schwender
Journal: J Med Chem Date: 1974-01 Impact factor: 7.446

6. Herpes simplex virus type I DNA polymerase. Kinetic properties of the associated 3'-5' exonuclease activity and its role in araAMP incorporation.

Authors: D Derse; Y C Cheng
Journal: J Biol Chem Date: 1981-08-25 Impact factor: 5.157

7. Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts.

Authors: L W Dow; D E Bell; L Poulakos; A Fridland
Journal: Cancer Res Date: 1980-05 Impact factor: 12.701

8. Effects of arabinonucleotides on ribonucleotide reduction by an enzyme system from rat tumor.

Authors: E C Moore; S S Cohen
Journal: J Biol Chem Date: 1967-05-10 Impact factor: 5.157

9. Treatment of acute myelogenous leukemia in children and adults.

Authors: H J Weinstein; R J Mayer; D S Rosenthal; B M Camitta; F S Coral; D G Nathan; E Frei
Journal: N Engl J Med Date: 1980-08-28 Impact factor: 91.245

10. Clinical pharmacology of deoxycoformycin.

Authors: P P Major; R P Agarwal; D W Kufe
Journal: Blood Date: 1981-07 Impact factor: 22.113

1 in total

Review 1. Evolution of the arabinosides and the pharmacology of fludarabine.

Authors: W Plunkett; V Gandhi
Journal: Drugs Date: 1994 Impact factor: 9.546

1 in total